Will aggressive policy tightening be the Fed's new mistake? Why analyze past mistakes when one can make new ones? Jay Powell has fired a starter pistol, launching a big monetary restriction race.
<p>Gilead Sciences shares rose 16% on Thursday after media reports of partial test results of the experimental drug Remdesivir in severe patients with coronavirus. </p> <p> </p>
Leave a Comment